<p>Summary of results, health and cost effects of ART scenarios with current prevention projected over 5 and 40 years (2011–2050).</p
<p>Unadjusted and adjusted hazard ratios (HR) according to CD4 count at start of ART and at 10 years...
<p>Duration on antiretroviral therapy (ART) and contribution to overall mortality among all ART user...
Increases in ART coverage from study start to study end in the intervention communities by sex and a...
<p><b>Notes:</b> ART scenarios refer to the CD4 level at which ART is offered. Enhanced prevention a...
<p>This bar chart represents the difference in Disability Adjusted Life Years (DALYs) between differ...
<p>These histograms show how projected expenditures over 40 years vary as a function of the ART scen...
<p>The cumulative person-years of ART provided per infection averted through the year 2020 for incre...
Scenario analysis: Results of the cost-consequence analysis from the NHS and hospital perspectives (...
<p>Proposed primary outcomes for evaluation of ART initiation in general adult populations.</p
<p>Treatment outcomes for all patients on ART at tertiary and secondary health facilities at 0–12 mo...
<p>Each bar in this figure shows a plot of reductions in deaths from disease 10 years after interven...
<p>Projected mortality reduction for the total study population on an annual and a cumulative basis ...
<p>Cumulative incidence of mortality up to four years after start of ART by region, corrected in Sou...
<p>Treatment outcomes for all patients on ART at tertiary and secondary health facilities at 13–24 m...
<p>Summary of patient outcomes in a cohort study of LTFU in a large South African ART program.</p
<p>Unadjusted and adjusted hazard ratios (HR) according to CD4 count at start of ART and at 10 years...
<p>Duration on antiretroviral therapy (ART) and contribution to overall mortality among all ART user...
Increases in ART coverage from study start to study end in the intervention communities by sex and a...
<p><b>Notes:</b> ART scenarios refer to the CD4 level at which ART is offered. Enhanced prevention a...
<p>This bar chart represents the difference in Disability Adjusted Life Years (DALYs) between differ...
<p>These histograms show how projected expenditures over 40 years vary as a function of the ART scen...
<p>The cumulative person-years of ART provided per infection averted through the year 2020 for incre...
Scenario analysis: Results of the cost-consequence analysis from the NHS and hospital perspectives (...
<p>Proposed primary outcomes for evaluation of ART initiation in general adult populations.</p
<p>Treatment outcomes for all patients on ART at tertiary and secondary health facilities at 0–12 mo...
<p>Each bar in this figure shows a plot of reductions in deaths from disease 10 years after interven...
<p>Projected mortality reduction for the total study population on an annual and a cumulative basis ...
<p>Cumulative incidence of mortality up to four years after start of ART by region, corrected in Sou...
<p>Treatment outcomes for all patients on ART at tertiary and secondary health facilities at 13–24 m...
<p>Summary of patient outcomes in a cohort study of LTFU in a large South African ART program.</p
<p>Unadjusted and adjusted hazard ratios (HR) according to CD4 count at start of ART and at 10 years...
<p>Duration on antiretroviral therapy (ART) and contribution to overall mortality among all ART user...
Increases in ART coverage from study start to study end in the intervention communities by sex and a...